[INM] YoY Quarter Result on 30-Jun-2019 [#Q4]

Stock
[INM] InMed Pharmaceuticals Inc.
Announcement Date
30-Jun-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q4]
Profit Trend
QoQ- -28.81%
YoY- -51.26%
Quarter Report
INM's Result
INM's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 515 0 0 0 0 0 0 -
PBT -7,870 -3,259 -1,951 -3,367 -2,226 -1,492 -395 64.61%
Tax -34 10 271 -27 -45 2 -1 79.94%
NP -7,870 -3,259 -1,951 -3,367 -2,226 -1,492 -395 64.61%
Tax Rate - - - - - - - -
Total Cost 8,385 3,259 1,951 3,367 2,226 1,492 395 66.36%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -1,528.88 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -12.22 -10.13 -9.32 -16.08 -11.72 -12.45 -4.92 16.36%
EPS Diluted -12.22 -10.13 -9.32 -16.08 -11.72 -12.45 -4.92 16.36%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.